Search

everythinglearnresearchcommunity

for

Search:↓

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Paclitaxel and nab-paclitaxel can be safe and effective for advanced gastric cancer patients on hemodialysis.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Guduchi and Yashtimadhu can reduce chemotherapy side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Enhancing immune response can improve cancer treatment effectiveness.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Further research is needed to develop effective cancer prevention strategies.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Docetaxel is effective against various cancers but mainly causes neutropenia.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Promising cancer treatments were found, but the manufacturer closed.

Combining Proton Minibeam with FLASH Radiotherapy may improve cancer treatment by reducing side effects and increasing effectiveness.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.